These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18639471)

  • 1. Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer.
    Zhao W; Xu Y; Kong D; Liu R; Zhang Z; Jin C; Zhang Z; Xiu Y
    Urol Oncol; 2009; 27(5):539-47. PubMed ID: 18639471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.
    Liu R; Sun J; Zhang Z; Xu Y
    Cell Biol Int; 2012 Oct; 36(10):863-72. PubMed ID: 22612256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Bcl-2 expression by a novel tumor-specific RNA interference system increases chemosensitivity to 5-fluorouracil in Hela cells.
    Huang SL; Wu Y; Yu H; Zhang P; Zhang XQ; Ying L; Zhao HF
    Acta Pharmacol Sin; 2006 Feb; 27(2):242-8. PubMed ID: 16412276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific targeting of prostate cancer cells in vitro by the suicide gene/prodrug system, uracil phosphoribosyltransferase/5-fluorouracil, under the control of prostate-specific membrane antigen promoter/enhancer.
    Zhao FJ; Zhang S; Yu ZM; Xia SJ; Li H
    Prostate Cancer Prostatic Dis; 2009; 12(2):166-71. PubMed ID: 18626508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of prostate-specific expressed recombinant plasmids with high transcriptional activity of prostate-specific membrane antigen (PSMA) promoter/enhancer.
    Zeng H; Wu Q; Li H; Wei Q; Lu Y; Li X; Wang F; Zhao F; Ding Z; Yang Y
    J Androl; 2005; 26(2):215-21. PubMed ID: 15713827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant adenovirus mediated prostate-specific enzyme pro-drug gene therapy regulated by prostate-specific membrane antigen (PSMA) enhancer/promoter.
    Zeng H; Wei Q; Huang R; Chen N; Dong Q; Yang Y; Zhou Q
    J Androl; 2007; 28(6):827-35. PubMed ID: 17522418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer].
    Zhao WM; Xiu YC; Xu Y; Wang YM; Cheng ZK; Yu Q; Kong DL
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):575-9. PubMed ID: 18210874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved effects of a double suicide gene system on prostate cancer cells by targeted regulation of prostate-specific membrane antigen promoter and enhancer.
    Zhang P; Zeng H; Wei Q; Lu Y; Li X; Wang J; Zhao F; Li H
    Int J Urol; 2008 May; 15(5):442-8. PubMed ID: 18452463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.
    Cao KY; Mao XP; Wang DH; Xu L; Yuan GQ; Dai SQ; Zheng BJ; Qiu SP
    Prostate; 2007 Dec; 67(16):1791-800. PubMed ID: 17929272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer.
    Li X; Zhang YP; Kim HS; Bae KH; Stantz KM; Lee SJ; Jung C; Jiménez JA; Gardner TA; Jeng MH; Kao C
    Cancer Res; 2005 Mar; 65(5):1941-51. PubMed ID: 15753394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The construction of recombinant plasmid with prostate-specific membrane antigen promoter controlling reporter gene expression].
    Zeng H; Li H; Liao YC; Li X; Wu Q; Yang YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):169-71. PubMed ID: 15807257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-step transcriptional amplification-lipid-based nanoparticles using PSMA or midkine promoter for suicide gene therapy in prostate cancer.
    Hattori Y; Maitani Y
    Cancer Sci; 2006 Aug; 97(8):787-98. PubMed ID: 16800821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of prostate specific membrane antigen/folate hydrolase transcription by an enhancer.
    Noss KR; Wolfe SA; Grimes SR
    Gene; 2002 Feb; 285(1-2):247-56. PubMed ID: 12039052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer.
    O'Keefe DS; Uchida A; Bacich DJ; Watt FB; Martorana A; Molloy PL; Heston WD
    Prostate; 2000 Oct; 45(2):149-57. PubMed ID: 11027414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction and expression of recombinant plasmid with prostate-specific membrane antigen promoter and enhancer regulating uracil phosphoribosyltransferase gene].
    Zhao FJ; Li H; Cheng HM; Zeng H; Wei Q; Li X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):172-5. PubMed ID: 15807258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells.
    Cao KY; Xu L; Zhang DM; Zhang XM; Zhang T; He X; Wang Z; Feng FS; Qiu SP; Shen GX
    Int J Oncol; 2012 Jun; 40(6):1977-85. PubMed ID: 22322627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transcriptional activities of tumor-specific survivin promoter and PSMA promoter and enhancer in human prostate cancer: evaluation and comparison].
    Luo XM; Liu JY; Su MQ; Hao XK
    Zhonghua Nan Ke Xue; 2012 Feb; 18(2):122-5. PubMed ID: 22568207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sox7 negatively regulates prostate-specific membrane antigen (PSMA) expression through PSMA-enhancer.
    Peng W; Guo L; Tang R; Liu X; Jin R; Dong JT; Xing CG; Zhou W
    Prostate; 2019 Mar; 79(4):370-378. PubMed ID: 30488457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter.
    Xie X; Zhao X; Liu Y; Young CY; Tindall DJ; Slawin KM; Spencer DM
    Hum Gene Ther; 2001 Mar; 12(5):549-61. PubMed ID: 11268287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Silencing effect of cell-specific RNA interference plasmid pPSMAe/p-shNS-ploy(A) loaded by transgenic vector Tf-PEG-PEI targeting nucleostemin on prostate cancer cells in vitro].
    Liu RL; Wang WY; Zhang ZH; Xu Y
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):725-9. PubMed ID: 23291063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.